STOCK BROKER REVIEW | INVESTING | UPCOMING IPO | ALGO TRADING | TECHNICAL ANALYSIS

Magenta Lifecare Limited IPO Review & Recommendations

 

Get Real-Time Updates on stock market trends and news

Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.

Join WhatsApp Channel

Magenta Lifecare Limited IPO

June 05, 2024 - June 07, 2024 Closed

Magenta Lifecare Limited IPO Review

Magenta Lifecare Limited IPO manufactures mattresses and pillows under the brand "Magenta" in India. Their product line includes a variety of mattresses such as memory foam, latex-based, bonded mattresses, pocketed springs, and various types of pillows including memory foam, molded memory foam, and conour foam pillows.

Magenta lifecare pvt. Ltd attributes its success to the quality of its products, which are valued by customers in various sectors such as retail, hotels, and institutions. Their commitment to innovation drives them to continually introduce new and inventive products with the support of their team. For example, they've added herbal mattresses infused with green tea and bamboo charcoal, as well as pet bed mattresses, to their product lineup. Additionally, they supply processed raw foam and adjustable bed frames (hydraulic beds) under their brand Magenta, which they import.

Magenta Lifecare Limited Products and Services

Magenta Lifecare Limited products and services are their products cater to everyone, from budget-friendly options to premium choices. Their carefully crafted products prioritize comfort, featuring ergonomic designs, thermal comfort, pressure relief, motion isolation, easy adjustment, and lasting durability. They believe their mattresses are designed to support, comfort, and keep the body cool, resulting in improved sleep quality. They offer mattresses with a wide range of customization options including fabric, shape, firmness, material, height, foam type & density, personalization, utility, and structure.

Magenta Medical ltd established a network of distributors, dealers, and retailers spanning several states in India. Their products are available through offline multi-brand outlets, dealer networks, and online e-commerce platforms. They appoint distributors on a regional basis.

Financial Overview  

Magenta Lifecare Private Limited company operates in a fiercely competitive and divided market. Despite this, with its efficient asset-light approach and effective cost management, the company is optimistic about sustaining and enhancing its performance, as demonstrated over the last 21 months. However, considering the aggressively priced issue based on FY24 annualized earnings, investors should be aware that a small equity post-IPO suggests a longer wait for returns. Well-informed or cash-rich investors should consider investing for long-term gains.

Frequently Asked Question

Pre-issue shareholding of the Magenta Lifecare Limited IPO promoter is 84.06%.
Lot size of the Magenta Lifecare Limited IPO is 4000 shares.
If you do not get the allotment of on Magenta Lifecare Limited IPO, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Closing date of Magenta Lifecare Limited IPO is June 07, 2024.
The meaning of " Magenta Lifecare Limited IPO GMP " is the Grey Market Premium (GMP) for the initial public offering (IPO) of sMagenta Lifecare Limited IPOon the current day.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in quest laboratories private limited using any neatest method at your convenience.
Magenta Lifecare Limited IPO share price ₹35 per share.
Magenta Lifecare Limited IPO share price Shares will be listed at BSE SME.
You will receive on Magenta Lifecare Limited IPO shares in your Demat account on June 10, 2024, if allotted.
Opening date of Magenta Lifecare Limited IPO is June 05, 2024.
Investing in an IPO carries risks such as market volatility, company performance, and economic conditions. It is important to read the prospectus and understand the risks before investing.
Allotment is based on the demand for the shares. If the IPO is oversubscribed, shares are allotted on a proportional or lottery basis.
Magenta Lifecare Limited IPO shares will get listed on June 12, 2024.
Post-issue shareholding of the Magenta Lifecare Limited IPO promoter is 59.59%.
The face value of Magenta Lifecare Limited IPO is ₹10 per share.
Comments for Magenta Lifecare Limited IPO Review & Recommendations

0 comments